Join to View Full Profile
Early Development OncologySpring House, PASpring House, PA 19477
Dr. Daskalakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Nephrology, 2003 - 2005
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Pittsburgh School of MedicineClass of 2000
Certifications & Licensure
NJ State Medical License 2006 - 2025
Publications & Presentations
PubMed
- 11 citationsPreclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.Min Chul Kwon, Jan Willem Thuring, Olivier Querolle, Xuedong Dai, Tinne Verhulst
Blood. 2024-09-12 - 4 citationsFirst-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay
Clinical and Translational Science. 2024-03-01 - 15 citationsFirst-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia.Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante
Clinical and Translational Science. 2023-03-01
Press Mentions
Leaders in the Nephrology CommunityFebruary 26th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
